Standout Papers

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia 2013 2026 2017 2021 363
  1. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia (2013)
    Michel Laviolette, David Gossage et al. Journal of Allergy and Clinical Immunology
  2. Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study (2014)
    Mario Castro, Sally E. Wenzel et al. The Lancet Respiratory Medicine

Immediate Impact

4 from Science/Nature 98 standout
Sub-graph 1 of 18

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
4 intermediate papers

Works of Yanping Wu being referenced

Clinical Efficacy of Benralizumab in Patients With Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials
2018
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
2014 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Yanping Wu 899 609 254 267 14 970
Julie Olsson 576 582 139 281 13 1.1k
Gun Almqvist 721 419 127 282 16 879
Stephanie L. Roseti 647 375 141 302 12 805
Angela Morgan 921 601 156 428 10 1.1k
JingYuan Feng 585 320 94 359 11 840
Tuyet‐Hang Pham 418 296 221 514 19 1.1k
K. Surrey 1080 797 73 123 9 1.1k
Jonathan Steinfeld 516 755 381 193 34 1.2k
Donald Rollins 730 274 354 650 20 1.1k
E Schotman 812 242 105 257 11 1.0k

All Works

Loading papers...

Rankless by CCL
2026